Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical study
Ontology highlight
ABSTRACT: Microarray analysis of transcriptional changes in biopsies of solid tumors from patients treated in a Phase I study with the Cdk inhibitor PHA-793887.
ORGANISM(S): Homo sapiens
PROVIDER: GSE18553 | GEO | 2010/05/14
SECONDARY ACCESSION(S): PRJNA121365
REPOSITORIES: GEO
ACCESS DATA